50242-0145
Perjeta
Pertuzumab
INJECTION, SOLUTION, CONCENTRATE
Intravenous
Pertuzumab
30.0
mg/mL
50242-0145-01
1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) > 14 mL in 1 VIAL, SINGLE-USE
June 8, 2012
Immunotherapy
Monoclonal Antibody
HER2
 
In Use